SOPH insider trading
NasdaqGS HealthcareSOPHiA GENETICS SA: insider trade history from SEC Form 4 filings.
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Company website: www.sophiagenetics.com
SOPH insider activity at a glance
FilingIQ tracks 168 insider transactions for SOPH in filings since Mar 20, 2026. The most recent transaction is dated Sep 21, 2026.
Across the full history, 1 open-market purchases
and 137 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SOPH insider trades is 57.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest SOPH Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SOPH?
- FilingIQ tracks 168 Form 4 insider transactions for SOPH (SOPHiA GENETICS SA), covering filings from Mar 20, 2026 onwards. 38 of those are dated within the last 90 days.
- Are SOPH insiders net buyers or net sellers?
- Across the full Form 4 history for SOPH, 1 transactions (1%) were open-market purchases and 137 (82%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SOPH insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is SOPH in?
- SOPHiA GENETICS SA (SOPH) is classified in the Healthcare sector, specifically Health Information Services, with a current market capitalisation of $355.48M.
Methodology & sources
Every SOPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.